Award
Eunice Kennedy Shriver National Institute of Child Health and Human Development 5R44HD112264-03
Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility
Recipient
Inherent Biosciences
Award Amount
$804,660.00
Ceiling
$804,660.00
Awarded
April 02, 2025
Identifier
5R44HD112264-03
NIH NICHD awarded $804,660 to Inherent Biosciences for developing a novel epigenetic test to improve treatment and health outcomes for men with severe infertility under the SBIR Fast-Track program.
Description
This project involves developing a diagnostic test for male infertility related to NOA, leveraging cell-free DNA analysis to predict sperm retrieval success and identify genetic causes. Funding is provided by NIH NICHD under the SBIR Fast-Track program.